http://www.aktiencheck.de aktiencheck.de aktiencheck.de Mon, 27 Apr 2026 12:14:30 +0200 2 http://www.aktiencheck.de/forum/NuPathe_zurueck_am_richtigen_Pfad_gen_Norden-A1C3AV-t453007 http://www.aktiencheck.de/forum/NuPathe_zurueck_am_richtigen_Pfad_gen_Norden-A1C3AV-t453007 NEWS, FDA Accepts NuPathe's Migraine Patch NDA Resubmission for Filing - Yahoo! FinanceFDA Accepts NuPathe's Migraine Patch NDA Resubmission for Filing - Yahoo! Financehttp://finance.yahoo.com/news/fda-accepts-nupathes-migraine-patch-110000965.htmlFDA Accepts NuPathe's Migraine Patch NDA Resubmission for Filing Print Alert Nupathe Inc. (MM) (NASDAQ:PATH) Intraday Stock Chart Today : Tuesday 31 July 2012 NuPathe Inc. (NASDAQ: PATH), a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, today announced that the company's New Drug Application (NDA) resubmission for its migraine patch (NP101) has been accepted for filing by the U.S. Food and Drug Administration (FDA). NuPathe has received a Prescription Drug User Fee Act (PDUFA) date, the target date for the FDA to complete its review of the NDA, of January 17, 2013. "As important as FDA acceptance of our NDA resubmission is for NuPathe, we believ [<a href="http://www.aktiencheck.de/forum/NuPathe_zurueck_am_richtigen_Pfad_gen_Norden-A1C3AV-t453007">mehr</a>]